285 related articles for article (PubMed ID: 34667307)
1. The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
Boyton RJ; Altmann DM
Nat Rev Immunol; 2021 Dec; 21(12):762-768. PubMed ID: 34667307
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of COVID-19 Symptoms During SARS-CoV-2 Infection Defines Waning of Humoral Immunity.
Wu J; Liang BY; Fang YH; Wang H; Yang XL; Shen S; Chen LK; Li SM; Lu SH; Xiang TD; Liu J; Le-Trilling VTK; Lu MJ; Yang DL; Deng F; Dittmer U; Trilling M; Zheng X
Front Immunol; 2021; 12():722027. PubMed ID: 34489971
[TBL] [Abstract][Full Text] [Related]
3. What the data say about asymptomatic COVID infections.
Nogrady B
Nature; 2020 Nov; 587(7835):534-535. PubMed ID: 33214725
[No Abstract] [Full Text] [Related]
4. Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection.
Sui Z; Dai X; Lu Q; Zhang Y; Huang M; Li S; Peng T; Xie J; Zhang Y; Wu C; Xia J; Dong L; Yang J; Huang W; Liu S; Wang Z; Li K; Yang Q; Zhou X; Wu Y; Liu W; Fang X; Peng K
Signal Transduct Target Ther; 2021 May; 6(1):181. PubMed ID: 33972497
[TBL] [Abstract][Full Text] [Related]
5. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
Peluso MJ; Deitchman AN; Torres L; Iyer NS; Munter SE; Nixon CC; Donatelli J; Thanh C; Takahashi S; Hakim J; Turcios K; Janson O; Hoh R; Tai V; Hernandez Y; Fehrman EA; Spinelli MA; Gandhi M; Trinh L; Wrin T; Petropoulos CJ; Aweeka FT; Rodriguez-Barraquer I; Kelly JD; Martin JN; Deeks SG; Greenhouse B; Rutishauser RL; Henrich TJ
Cell Rep; 2021 Aug; 36(6):109518. PubMed ID: 34358460
[TBL] [Abstract][Full Text] [Related]
6. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
[TBL] [Abstract][Full Text] [Related]
7. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.
Yang Y; Wang X; Du RH; Zhang W; Si HR; Zhu Y; Shen XR; Li Q; Li B; Men D; Zhou YN; Wang H; Tong XL; Zhang XE; Shi ZL; Zhou P
Emerg Microbes Infect; 2021 Dec; 10(1):905-912. PubMed ID: 33870851
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients.
Chen Y; Li P; Ding Y; Liu M; Liu L; Yi B; Wu T; Dong H; Lao X; Ding K; Wang H; Zhang D; Tan X; Wang Z; Xu G; Cao G
J Infect Public Health; 2021 Jul; 14(7):845-851. PubMed ID: 34118734
[TBL] [Abstract][Full Text] [Related]
9. The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19.
Almadhi MA; Abdulrahman A; Sharaf SA; AlSaad D; Stevenson NJ; Atkin SL; AlQahtani MM
Int J Infect Dis; 2021 Apr; 105():656-661. PubMed ID: 33647516
[TBL] [Abstract][Full Text] [Related]
10. Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection.
Wang Z; Yang X; Zhong J; Zhou Y; Tang Z; Zhou H; He J; Mei X; Tang Y; Lin B; Chen Z; McCluskey J; Yang J; Corbett AJ; Ran P
Nat Commun; 2021 Mar; 12(1):1724. PubMed ID: 33741972
[TBL] [Abstract][Full Text] [Related]
11. The immunology and immunopathology of COVID-19.
Merad M; Blish CA; Sallusto F; Iwasaki A
Science; 2022 Mar; 375(6585):1122-1127. PubMed ID: 35271343
[TBL] [Abstract][Full Text] [Related]
12. Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021.
Budziar W; Gembara K; Harhala M; Szymczak A; Jędruchniewicz N; Baniecki K; Pikies A; Nahorecki A; Hoffmann A; Kardaś A; Szewczyk-Dąbrowska A; Klimek T; Kaźmierczak Z; Witkiewicz W; Barczyk K; Dąbrowska K
PLoS One; 2022; 17(2):e0253638. PubMed ID: 35113873
[TBL] [Abstract][Full Text] [Related]
13. Low In-School COVID-19 Transmission and Asymptomatic Infection Despite High Community Prevalence.
Katz SE; McHenry R; Mauer LG; Chappell JD; Stewart LS; Schmitz JE; Halasa N; Edwards KM; Banerjee R
J Pediatr; 2021 Oct; 237():302-306.e1. PubMed ID: 34144028
[TBL] [Abstract][Full Text] [Related]
14. Assessment of global asymptomatic SARS-CoV-2 infection and management practices from China.
Chen Z; Wang B; Mao S; Ye Q
Int J Biol Sci; 2021; 17(4):1119-1124. PubMed ID: 33867834
[TBL] [Abstract][Full Text] [Related]
15. Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions.
Siemińska I; Węglarczyk K; Surmiak M; Kurowska-Baran D; Sanak M; Siedlar M; Baran J
Front Immunol; 2021; 12():748097. PubMed ID: 34659245
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 transmission without symptoms.
Rasmussen AL; Popescu SV
Science; 2021 Mar; 371(6535):1206-1207. PubMed ID: 33737476
[No Abstract] [Full Text] [Related]
17. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M
Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009
[TBL] [Abstract][Full Text] [Related]
18. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
[TBL] [Abstract][Full Text] [Related]
19. Durable Antibody Responses in Staff at Two Long-Term Care Facilities, during and Post SARS-CoV-2 Outbreaks.
Gallichotte EN; Nehring M; Young MC; Pugh S; Sexton NR; Fitzmeyer E; Quicke KM; Richardson M; Pabilonia KL; Ehrhart N; Fosdick BK; VandeWoude S; Ebel GD
Microbiol Spectr; 2021 Sep; 9(1):e0022421. PubMed ID: 34287058
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
Popova AY; Smirnov VS; Andreeva EE; Babura EA; Balakhonov SV; Bashketova NS; Bugorkova SA; Bulanov MV; Valeullina NN; Vetrov VV; Goryaev DV; Detkovskaya TN; Ezhlova EB; Zaitseva NN; Istorik OA; Kovalchuk IV; Kozlovskikh DN; Kombarova SY; Kurganova OP; Lomovtsev AE; Lukicheva LA; Lyalina LV; Melnikova AA; Mikailova OM; Noskov AK; Noskova LN; Oglezneva EE; Osmolovskaya TP; Patyashina MA; Penkovskaya NA; Samoilova LV; Stepanova TF; Trotsenko OE; Totolian AA
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
